ASCORBIC ACID

Ascorbic Acid Adverse Events Reported to the FDA Over Time

How are Ascorbic Acid adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ascorbic Acid, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ascorbic Acid is flagged as the suspect drug causing the adverse event.

Most Common Ascorbic Acid Adverse Events Reported to the FDA

What are the most common Ascorbic Acid adverse events reported to the FDA?

Nausea	32 (1.48%)
Vomiting	29 (1.34%)
Drug Interaction	27 (1.25%)
Dyspnoea	26 (1.2%)
Fatigue	25 (1.16%)
Pyrexia	25 (1.16%)
Diarrhoea	23 (1.06%)
Asthenia	21 (.97%)
Dehydration	19 (.88%)
Renal Failure Acute	18 (.83%)
Anaemia	17 (.79%)
	Show More
Condition Aggravated	17 (.79%)
Confusional State	16 (.74%)
Disease Progression	16 (.74%)
Hypotension	16 (.74%)
Toxic Epidermal Necrolysis	16 (.74%)
Abdominal Pain	15 (.69%)
Drug Exposure During Pregnancy	15 (.69%)
Malaise	15 (.69%)
Pneumonia	15 (.69%)
Back Pain	13 (.6%)
Cerebral Haemorrhage	13 (.6%)
Pleural Effusion	13 (.6%)
Dizziness	12 (.55%)
Sepsis	12 (.55%)
Somnolence	12 (.55%)
Anorexia	11 (.51%)
Convulsion	11 (.51%)
Malignant Neoplasm Progression	11 (.51%)
Renal Failure	11 (.51%)
Acute Hepatic Failure	10 (.46%)
Arthralgia	10 (.46%)
Aspartate Aminotransferase Increase...	10 (.46%)
Multiple Myeloma	10 (.46%)
Oedema	10 (.46%)
Thrombocytopenia	10 (.46%)
Atrial Fibrillation	9 (.42%)
Constipation	9 (.42%)
Insomnia	9 (.42%)
Jaundice	9 (.42%)
Muscular Weakness	9 (.42%)
Pain	9 (.42%)
Rash	9 (.42%)
Alanine Aminotransferase Increased	8 (.37%)
Blood Pressure Increased	8 (.37%)
Chills	8 (.37%)
Haemoglobin Decreased	8 (.37%)
Hepatic Necrosis	8 (.37%)
Hypercalcaemia	8 (.37%)
Lethargy	8 (.37%)
Liver Disorder	8 (.37%)
Pancytopenia	8 (.37%)
Pericardial Effusion	8 (.37%)
Pulmonary Haemorrhage	8 (.37%)
Septic Shock	8 (.37%)
Tachycardia	8 (.37%)
Abdominal Distension	7 (.32%)
Convulsive Threshold Lowered	7 (.32%)
Decreased Appetite	7 (.32%)
Dyspepsia	7 (.32%)
Electrocardiogram Qt Prolonged	7 (.32%)
Fall	7 (.32%)
Foetal Growth Retardation	7 (.32%)
Haematemesis	7 (.32%)
Headache	7 (.32%)
Hyperglycaemia	7 (.32%)
Stomatitis	7 (.32%)
Tremor	7 (.32%)
Urinary Tract Infection	7 (.32%)
Agitation	6 (.28%)
Aphthous Stomatitis	6 (.28%)
Ascites	6 (.28%)
Body Temperature Increased	6 (.28%)
Cardiac Disorder	6 (.28%)
Cataract	6 (.28%)
Chest Pain	6 (.28%)
Cough	6 (.28%)
Death	6 (.28%)
Drug Ineffective	6 (.28%)
Erythema	6 (.28%)
Flushing	6 (.28%)
General Physical Health Deteriorati...	6 (.28%)
Hyperkalaemia	6 (.28%)
Hypoaesthesia	6 (.28%)
Incorrect Dose Administered	6 (.28%)
Melaena	6 (.28%)
Mental Status Changes	6 (.28%)
Oral Herpes	6 (.28%)
Placental Infarction	6 (.28%)
Prothrombin Time Prolonged	6 (.28%)
Pruritus	6 (.28%)
Pulmonary Oedema	6 (.28%)
Respiratory Failure	6 (.28%)
Ulcerative Keratitis	6 (.28%)
Vision Blurred	6 (.28%)
Abdominal Pain Upper	5 (.23%)
Acute Respiratory Distress Syndrome	5 (.23%)
Anxiety	5 (.23%)
Blood Bilirubin Increased	5 (.23%)
Blood Iron Increased	5 (.23%)
Blood Sodium Decreased	5 (.23%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ascorbic Acid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ascorbic Acid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ascorbic Acid

What are the most common Ascorbic Acid adverse events reported to the FDA?

Gastrointestinal Signs	105 (4.85%)
Epidermal And Dermal Conditions	82 (3.79%)
Neurological	81 (3.74%)
Respiratory	77 (3.56%)
Infections - Pathogen Unspecified	70 (3.24%)
Hepatic And Hepatobiliary	64 (2.96%)
Renal Disorders	48 (2.22%)
Hematology Investigations	44 (2.03%)
Therapeutic And Nontherapeutic Effe...	43 (1.99%)
Gastrointestinal Motility And Defec...	40 (1.85%)
Cardiac Arrhythmias	38 (1.76%)
	Show More
Cardiac And Vascular Investigations	37 (1.71%)
Medication Errors	36 (1.66%)
Electrolyte And Fluid Balance Condi...	35 (1.62%)
Hepatobiliary	35 (1.62%)
Musculoskeletal And Connective Tiss...	34 (1.57%)
Decreased And Nonspecific Blood Pre...	30 (1.39%)
Urinary Tract Signs	27 (1.25%)
Anemias Nonhemolytic And Marrow Dep...	25 (1.16%)
Body Temperature Conditions	25 (1.16%)
Appetite And General Nutritional	24 (1.11%)
Chemical Injury And Poisoning	24 (1.11%)
Deliria	24 (1.11%)
Lower Respiratory Tract Disorders	24 (1.11%)
Central Nervous System Vascular	23 (1.06%)
Muscle	22 (1.02%)
Bacterial Infectious	21 (.97%)
Gastrointestinal Hemorrhages	21 (.97%)
Injuries	21 (.97%)
Seizures	21 (.97%)
Oral Soft Tissue Conditions	20 (.92%)
Anxiety Disorders	18 (.83%)
Pleural	18 (.83%)
Renal And Urinary Tract Investigati...	18 (.83%)
Cardiac Disorder Signs	16 (.74%)
Joint	16 (.74%)
Metabolic, Nutritional And Blood Ga...	16 (.74%)
Water, Electrolyte And Mineral	16 (.74%)
Bone, Calcium, Magnesium And Phosph...	15 (.69%)
Miscellaneous And Site Unspecified ...	15 (.69%)
Glucose Metabolism Disorders	14 (.65%)
Movement Disorders	14 (.65%)
Procedural And Device Related Injur...	14 (.65%)
White Blood Cell	13 (.6%)
Allergic Conditions	11 (.51%)
Ocular Infections, Irritations And ...	11 (.51%)
Pericardial	11 (.51%)
Physical Examination Topics	11 (.51%)
Sleep Disorders	11 (.51%)
Upper Respiratory Tract Disorders	11 (.51%)
Mental Impairment	10 (.46%)
Nephropathies	10 (.46%)
Plasma Cell Neoplasms	10 (.46%)
Platelet	10 (.46%)
Vascular	10 (.46%)
Viral Infectious	10 (.46%)
Fetal Complications	9 (.42%)
Metastases	9 (.42%)
Pulmonary Vascular	9 (.42%)
Administration Site Reactions	8 (.37%)
Fatal Outcomes	8 (.37%)
Gastrointestinal Ulceration And Per...	8 (.37%)
Placental, Amniotic And Cavity Diso...	8 (.37%)
Tongue Conditions	8 (.37%)
Urolithiases	8 (.37%)
Angiedema And Urticaria	7 (.32%)
Cardiac Valve	7 (.32%)
Dental And Gingival Conditions	7 (.32%)
Encephalopathies	7 (.32%)
Enzyme	7 (.32%)
Fungal Infectious	7 (.32%)
Headaches	7 (.32%)
Increased Intracranial Pressure And...	7 (.32%)
Leukemias	7 (.32%)
Lipid Analyses	7 (.32%)
Microbiology And Serology	7 (.32%)
Myocardial	7 (.32%)
Peritoneal And Retroperitoneal Cond...	7 (.32%)
Vascular Hemorrhagic	7 (.32%)
Anterior Eye Structural Change, Dep...	6 (.28%)
Arteriosclerosis, Stenosis, Vascula...	6 (.28%)
Bone And Joint Injuries	6 (.28%)
Coronary Artery	6 (.28%)
Heart Failures	6 (.28%)
Lifestyle Issues	6 (.28%)
Neonatal And Perinatal Conditions	6 (.28%)
Psychiatric	6 (.28%)
Toxicology And Therapeutic Drug Mon...	6 (.28%)
Vascular Hypertensive	6 (.28%)
Vision	6 (.28%)
Bile Duct	5 (.23%)
Bronchial Disorders	5 (.23%)
Exocrine Pancreas Conditions	5 (.23%)
Metabolism	5 (.23%)
Ocular Structural Change, Deposit A...	5 (.23%)
Skin Appendage Conditions	5 (.23%)
Suicidal And Self-injurious Behavio...	5 (.23%)
Bone Disorders	4 (.18%)
Congenital And Hereditary	4 (.18%)
Disturbances In Thinking	4 (.18%)
Endocrine Neoplasms Malignant And U...	4 (.18%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ascorbic Acid, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ascorbic Acid is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.